آخر تحديث :
09/04/2024
الاستقرار والتوافق للادويه عن

نرحب بك في Stabilis. إذا كنت ترغب في الحصول على النشرة الإخبارية الفصلية،اكتب عنوان بريدك الإلكتروني هنا

سجل

إذا كان لديك أي أسئلة أو تعليقات، الرجاء الاتصال ب: infostab@stabilis.org

قاعدة البيانات  
مراجع : 2765
مركبات : 859
الفئة الدوائية : 46
استقرار المحلول : 6345
الاستقرار في مخاليط : 1245
التوافق : 12364
الإسم التجاري : 5055
أخبار - مركبات  
المضادة للالتهابات المراهم Diclofenac 08/04/2024
مختلف حقن Ranibizumab 08/03/2024
مختلف حقن Faricimab 08/03/2024
مختلف حقن Disodium glucose-1-phosphate tetrahydrate 18/01/2024
المضادة للفيروسات حقن Remdesivir 13/09/2023
أدوية الاعصاب عن طريق الفم  Lurasidone 28/08/2023
مختلف كبسولة Cholic acid 12/06/2023
مختلف عن طريق الفم  L-Methionine 22/05/2023
أدوية تخدير عام تحميلة Pentobarbital 22/05/2023
مضاد حيوي كبسولة Erythromycine 22/05/2023
المضادة للفيروسات قطرات العين Ganciclovir 02/03/2023
مزيل القلق حقن Remimazolam 28/02/2023
مختلف حقن Teduglutide 24/02/2023
مختلف المراهم Resorcinol 19/01/2023
أدويه مخفضه للضغط كبسولة Clonidine hydrochloride 05/12/2022
مضاد حيوي حقن Omadacycline 20/11/2022
المضادة للسرطان المخدرات حقن Trastuzumab deruxtecan 17/11/2022
المضادة للسرطان المخدرات عن طريق الفم  Vinorelbine 05/11/2022
مضاد حيوي حقن Cefradine 06/09/2022
مختلف حقن Ambroxol 06/09/2022
أخبار - مراجع  
تاريخ الادخال
4816 Stability Evaluation of Bracketed Diclofenac Sodium USP in VersaPro Cream Base, Versa Pro Gel Base and PLO Gel Mediflo30 Compound Kit. Int J Pharm Compound 26/03/2024
4802 Glucose-1-Phosphate disodique tétrahydraté (Phocytan®) - Résumé des caractéristiques du produit Aguettant Laboratory 18/01/2024
4798 A silicone Oil-Free Syringe Tailored for Intravitreal Injection of Biologics. Frontiers in Ophthalmology 12/01/2024
4799 Stability of Voriconazole 10 mg/mL in IsoptoTears 0.5% stored in Glass Vials And Low Density Polyethylene Droppers at 4°C and 25°C for 28 Days. 12/01/2024
4800 Stability of Dr.Reddy’s Cabazitaxel Following Reconstitution with Manufacturer’s Diluent & Dilution with Sodium Chloride and Dextrose 5% in non-PVC non-DEHP bags and Original Glass Vials at 25°C, 4°C and -20°C. 12/01/2024
4792 Evaluation of the stability of aciclovir in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy. EJHP 15/12/2023
4789 Stability of sulfadiazine sugar-free oral suspensions for the treatment of congenital toxoplasmosis. Braz J Pharm Sci 15/11/2023
4790 Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties. Int J Retina Vitreous 15/11/2023
4786 Etude de stabilité de solutions de pembrolizumab à 1 et 4 mg/mL à 5 et 25°C dans des poches de NaCl 0,9% en polyoléfine . SFPO Congress 07/11/2023
4784 In-use stability of ready-to- administer daratumumab subcutaneous injection solution in plastic syringes. EJHP 04/11/2023
4785 Darzalex 1800 mg solution for injection - Summary of Product characteristics. Janssen-Cilag International NV 04/11/2023
4782 In‑Use Stability of SB12 (Eculizumab, Soliris Biosimilar) Diluted in Saline and Dextrose Infusion Solution after an Extended Storage Period. Drugs R D 07/10/2023
4780 Extemporaneous Topical Minoxidil Solutions for the treatment of Alopecia : Stability Studies and Incorporation Tests of Active Ingredients in ALOPLUS FAST Base. Int J Pharm Compound 13/09/2023
4776 Antiemetic Drugs Compatibility Evaluation with Paediatric Parenteral Nutrition Admixtures. Pharmaceutics 08/09/2023
4777 Physicochemical and microbiological stability of azathioprine suspensions in PCCA base Suspendit. Int J Pharm Compound 08/09/2023
4778 Chemical stability of epinephrine 10 µg/mL doluted in 0.9% sodium chloride and stored in polypropylene syringes at 4°C and 25°C. Int J Pharm Compound 08/09/2023
4773 Predictive stability, novel HPLC-MS analysis and semi-automatic compounding process for the emergency implementation of a production line of pancuronium in injectable solution. Eur J Pharm Sci 03/09/2023
4770 Use of a liquid chromatography-tandem mass spectrometry method to assess the concentration of epinephrine, norepinephrine, and phenylephrine stored in plastic syringes. Pharmaceutical Technology in Hospital Pharmacy 22/08/2023
4772 Stability of Opened Durvalumab (IMFINZI) Vials. The Beginning of the End of Costly Product Wastage? J Pharm Sci 22/08/2023
4767 Physicochemical stability of durvalumab (Imfinzi® ) concentrate for solution in original vials after first opening. Pharmaceutical Technology in Hospital Pharmacy 02/08/2023
4763 Physicochemical stability of urea-containing Mitomycin C preparations in glass vials (1.0 mg/mL) and plastic syringes (2.0, 0.4, 0.2 mg/mL) Pharmaceutical Technology in Hospital Pharmacy 02/08/2023
4766 Stability of omeprazole extemporaneous oral solution in Chopin Base. Int J Pharm Compound 02/08/2023
4768 Y-site injection physical compatibility of remdesivr with select intravenous drugs used in palliative care and for treating coronavirus disease 2019. Journal of Nippon Medical school 02/08/2023
4769 Cisatracurium Besylate 10 mg/mL Solution Compounded in a Hospital Pharmacy to Prevent Drug Shortages : A Stability Study Involving Four Degradation Products. Pharmaceutics 02/08/2023
4762 Physicochemical stability of carmustine-containing medicinal products after reconstitution and after dilution to ready-to-administer infusion solutions stored refrigerated or at room temperature EJHP 01/08/2023
4761 Physicochemical stability of Cabazitaxel Zentiva® solution in vials after opening and diluted- solutions in three infusion bags. Pharmaceutical Technology in Hospital Pharmacy 28/07/2023
4758 Stability Study and Simultaneous Determination of Norepinephrine, Moxifloxacin, and Piperacillin + Tazobactam Mixtures Applied in Intensive Care Medicine . Curr Pharm Anal 10/07/2023
4759 Stability of 5-fluorouracil at 4°C, 25°C, and 33°C stored in NiproSureFuser+ Ambulatory Balloon Infusers. Sunnybrook Healt Science Centre 10/07/2023
4757 In Vitro Assessment of Compounded Lurasidone Suspensions for Enteral Feeding Tubes. Hosp Pharm 06/06/2023
4756 Physicochemical stability of PF-06439535 (bevacizumab-bvzr; Zirabev®), a bevacizumab biosimilar, under extended in-use conditions. J Oncol Pharm Practice 16/05/2023

  Mentions Légales